Home › Clinical Trials › Participate

Participate in Groundbreaking Research

Access cutting-edge therapies, contribute to medical advancement, and receive comprehensive care through Zenth Health Sciences' global clinical research network.

FDA/EMA Compliant
IRB Approved
HIPAA & GDPR Protected

Showing 6 of 42 active studies matching your criteria

ZHS-2026-0412 Recruiting

Phase III Trial of AZT-7X in Early-Stage Non-Small Cell Lung Cancer

Phase III Multiple Sites (NA, EU)

Evaluating the efficacy and safety of AZT-7X monotherapy versus standard of care in treatment-naïve NSCLC patients with EGFR mutations. Involves 18 monthly visits, CT imaging, and biomarker assessments.

Check Eligibility View Full Protocol
ZHS-2025-1189 Actively Enrolling

Phase II Study of Neural-Regenerative Therapy in Moderate Alzheimer's Disease

Phase II London, Tokyo, Boston

Investigating intranasal delivery of neurotrophic factors to improve cognitive function and daily living activities in patients with mild-to-moderate Alzheimer's. 24-week open-label study with MRI monitoring.

Check Eligibility View Full Protocol
ZHS-2026-0305 Recruiting

Phase I/II Safety & Dose-Escalation of Cardiac-Exosome Therapy Post-MI

Phase I/II Munich, Singapore

First-in-human study assessing cardiovascular recovery metrics following intracoronary administration of engineered exosomes in patients 3-14 days post-myocardial infarction. Echo & biomarker endpoints.

Check Eligibility View Full Protocol
ZHS-2025-0977 Active

Phase III Randomized Trial of AZT-44B in Rheumatoid Arthritis

Phase III Global (28 Countries)

Comparing AZT-44B subcutaneous injection to placebo in patients with moderate-to-severe RA inadequately responding to DMARDs. Primary endpoint: ACR50 response at week 24.

View Full Protocol

How to Participate

1

Search & Match

Use our filters to find studies matching your condition, location, and availability. Review detailed protocols and eligibility criteria.

2

Initial Screening

Submit a secure inquiry. Our research coordinators will contact you to verify medical history, conduct preliminary assessments, and schedule site visits.

3

Informed Consent

Meet with the principal investigator to discuss risks, benefits, procedures, and your rights. All participation is voluntary and fully documented.

4

Active Participation

Attend scheduled visits, complete questionnaires, receive interventions, and provide follow-up data. You'll be monitored by a dedicated care team throughout.

Safety, Ethics & Compliance

⟐

IRB & Regulatory Oversight

Every trial undergoes rigorous Institutional Review Board approval and complies with FDA, EMA, ICH-GCP, and local regulatory standards.

⚖

Participant Rights & Withdrawal

You may withdraw at any time without penalty or impact to your standard medical care. All decisions are voluntary and confidential.

🔒

Data Privacy & Security

Medical records and trial data are encrypted, anonymized where applicable, and protected under HIPAA, GDPR, and SOC 2 Type II compliance.

🩺

Adverse Event Monitoring

Continuous pharmacovigilance and Data Safety Monitoring Boards ensure real-time safety tracking and immediate intervention if needed.

Frequently Asked Questions

Yes. All investigational treatments, study-related procedures, and standard care assessments required by the protocol are provided at no cost. Travel, lodging, and non-study medical expenses may be compensated depending on the trial's sponsor and location. Please contact the study coordinator for specific financial support details.
Duration varies significantly by phase and condition. Phase I safety studies may last weeks to months, while Phase III efficacy trials can span 1-3 years. Each protocol clearly outlines the expected commitment, visit frequency, and follow-up requirements before you enroll.
Your safety is our priority. All adverse events are documented and reported to the principal investigator and safety monitoring board. If you experience concerning symptoms, you will receive immediate medical attention. You may pause or withdraw from the study at any time without jeopardizing your care.
Eligibility depends on the specific trial's inclusion/exclusion criteria. Some studies allow concomitant medications with restrictions, while others require a washout period. The screening process will evaluate your full medication history to determine compatibility and safety.

Questions or Need Guidance?

Our clinical research coordinators are available 24/7 to help you navigate trials, understand protocols, and find the right match.

Contact Research Support →